1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan Neuropathic Pain Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Japan Neuropathic Pain Market
4. Japan Neuropathic Pain Market by
Type
4.1. Phantom Limb Pain
4.2. Trigeminal Neuralgia
4.3. Post Herpetic Neuralgia
4.4. Post-traumatic Neuropathy
5. Japan Neuropathic Pain Market by
Indication
5.1. Spinal Stenosis
5.2. Diabetic Neuropathy
6. Japan Neuropathic Pain Market by
Diagnosis
6.1. Imaging Physical
Examination
6.1.1. Electromyography
6.1.2. MRI
6.1.3. CT
6.2. Blood Tests
7. Japan Neuropathic Pain Market by
Treatment
7.1. Medication Type
7.2. NSAIDs Type
7.2.1. Naproxen
7.2.2. Ibuprofen
7.2.3. Others
7.3. Antidepressant Drugs Type
7.3.1. Tricyclic Antidepressants
7.3.2. Serotonin Noradrenaline
7.4. Multimodal Therapy
8. Japan Neuropathic Pain Market by
Distribution Channel
8.1. Retail Pharmacies and Drug Stores
8.2. Online Pharmacies
9. Japan Neuropathic Pain Market by
End User
9.1. Hospitals
9.2. Clinics
10. Company Profiles
10.1.
Company 1
10.2.
Company 2
10.3.
Company 3
10.4.
Company 4
10.5.
Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan Neuropathic Pain Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Japan Neuropathic Pain Market
4. Japan Neuropathic Pain Market by
Type
4.1. Phantom Limb Pain
4.2. Trigeminal Neuralgia
4.3. Post Herpetic Neuralgia
4.4. Post-traumatic Neuropathy
5. Japan Neuropathic Pain Market by
Indication
5.1. Spinal Stenosis
5.2. Diabetic Neuropathy
6. Japan Neuropathic Pain Market by
Diagnosis
6.1. Imaging Physical
Examination
6.1.1. Electromyography
6.1.2. MRI
6.1.3. CT
6.2. Blood Tests
7. Japan Neuropathic Pain Market by
Treatment
7.1. Medication Type
7.2. NSAIDs Type
7.2.1. Naproxen
7.2.2. Ibuprofen
7.2.3. Others
7.3. Antidepressant Drugs Type
7.3.1. Tricyclic Antidepressants
7.3.2. Serotonin Noradrenaline
7.4. Multimodal Therapy
8. Japan Neuropathic Pain Market by
Distribution Channel
8.1. Retail Pharmacies and Drug Stores
8.2. Online Pharmacies
9. Japan Neuropathic Pain Market by
End User
9.1. Hospitals
9.2. Clinics
10. Company Profiles
10.1.
Company 1
10.2.
Company 2
10.3.
Company 3
10.4.
Company 4
10.5.
Company 5